30-day FRN Vol. 79, No. 96 Monday, May 19, 2014 Notices 28774 DHS-2013-0032 NPPD Generic Clearance

30-day FRN Vol. 79, No. 96 Monday, May 19, 2014 Notices 28774 DHS-2013-0032 NPPD Generic Clearance.pdf

Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery

30-day FRN Vol. 79, No. 96 Monday, May 19, 2014 Notices 28774 DHS-2013-0032 NPPD Generic Clearance

OMB: 1670-0027

Document [pdf]
Download: pdf | pdf
mstockstill on DSK4VPTVN1PROD with NOTICES

28744

Federal Register / Vol. 79, No. 96 / Monday, May 19, 2014 / Notices

Health, 6701 Rockledge Drive, Room 4146,
MSC 7806, Bethesda, MD 20892, 301–435–
1016, [email protected].
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Health Disparities and Equity Promotion
Study Section.
Date: June 12–13, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Wyndham Grand RiverFront, 71 E
Wacker Drive, Chicago, IL 60601.
Contact Person: Delia Olufokunbi Sam,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3158,
MSC 7770, Bethesda, MD 20892, 301–435–
0684, [email protected].
Name of Committee: Vascular and
Hematology Integrated Review Group;
Atherosclerosis and Inflammation of the
Cardiovascular System Study Section.
Date: June 12–13, 2014.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda,
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Natalia Komissarova,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5207,
MSC 7846, Bethesda, MD 20892, 301–435–
1206, [email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Cancer Diagnostics and
Treatments.
Date: June 12–13, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Zhang-Zhi Hu, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6186,
MSC 7804, Bethesda, MD 20892, (301) 594–
2414, [email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Biomedical
Imaging and Engineering Area Review.
Date: June 12, 2014.
Time: 11:45 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Mehrdad Mohseni, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5211,
MSC 7854, Bethesda, MD 20892, 301–435–
0484, [email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Mechanisms
of Neurodegeneration.
Date: June 12, 2014.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.

VerDate Mar<15>2010

17:17 May 16, 2014

Jkt 232001

Place: Hotel Palomar, 2121 P Street NW.,
Washington, DC 20037.
Contact Person: Carole L Jelsema, Ph.D.,
Chief and Scientific Review Officer, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4176,
MSC 7850, Bethesda, MD 20892, (301) 435–
1248, [email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR13–345:
Development of Appropriate Pediatric
Formulations.
Date: June 12, 2014.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Yuan Luo, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5207, MSC 7846, Bethesda, MD
20892, 301–915–6303, [email protected].
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review Group;
Urologic and Genitourinary Physiology and
Pathology.
Date: June 13, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza Washington National
Airport, 1489 Jefferson Davis Hwy, Arlington,
VA 22202.
Contact Person: Ryan G Morris, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4205,
MSC 7814, Bethesda, MD 20892, 301–435–
1501, [email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Basic and Integrative
Bioengineering.
Date: June 13, 2014.
Time: 11:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: David R Filpula, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6181,
MSC 7892, Bethesda, MD 20892, 301–435–
2902, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 13, 2014.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–11454 Filed 5–16–14; 8:45 am]
BILLING CODE 4140–01–P

PO 00000

Frm 00074

Fmt 4703

Sfmt 4703

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; Clinical
Trials Outcome Development.
Date: June 12, 2014.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Suite 800, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Xincheng Zheng, MD,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute of
Arthritis, Musculoskeletal and Skin Diseases,
NIH, 6701 Democracy Boulevard, Suite 800,
Bethesda, MD 20892, 301–594–4953,
[email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: May 13, 2014.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–11458 Filed 5–16–14; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HOMELAND
SECURITY
[Docket No. DHS–2013–0032]

Agency Information Collection
Activities: Proposed Collection;
Comment Request; Generic Clearance
for the Collection of Qualitative
Feedback on Agency Service Delivery
National Protection and
Programs Directorate, DHS.
ACTION: 30-Day notice of submission of
information collection approval from
AGENCY:

E:\FR\FM\19MYN1.SGM

19MYN1

Federal Register / Vol. 79, No. 96 / Monday, May 19, 2014 / Notices
the Office of Management and Budget
and request for comments.
As part of a Federal
Government-wide effort to streamline
the process to seek feedback from the
public on service delivery, the
Department of Homeland Security
(DHS), National Protection and
Programs Directorate (NPPD), Office of
the Chief Information Office has
submitted a Generic Information
Collection Request (Generic ICR):
‘‘Generic Clearance for the Collection of
Qualitative Feedback on Agency Service
Delivery’’ to OMB for approval under
the Paperwork Reduction Act (PRA) (44
U.S.C. 3501 et. seq.).
DATES: Comments are encouraged and
will be accepted until June 18, 2014.
This process is conducted in accordance
with 5 CFR 1320.10.
ADDRESSES: Written comments may be
submitted to the Office of Information
and Regulatory Affairs, OMB.
Comments should be addressed to OMB
Desk Officer, DHS, Office of Civil Rights
and Civil Liberties. Comments must be
identified by DHS–2013–0032 and may
be submitted by one of the following
methods:
• Federal eRulemaking Portal: http://
www.regulations.gov.
• Email: oira_submission@
omb.eop.gov. Include the docket
number in the subject line of the
message.
• Fax: (202) 395–5806
Instructions: All submissions received
must include the words ‘‘Department of
Homeland Security’’ and the docket
number for this action. Comments
received will be posted without
alteration at http://www.regulations.gov,
including any personal information
provided.
FOR FURTHER INFORMATION CONTACT: To
request additional information, please
Contact: DHS/NPPD, Office of the Chief
Information Office, nppd-prac@
hq.dhs.gov.
SUPPLEMENTARY INFORMATION:
Title: Generic Clearance for the
Collection of Qualitative Feedback on
Agency Service Delivery.
Abstract: The proposed information
collection activity provides a means to
garner qualitative customer and
stakeholder feedback in an efficient,
timely manner, in accordance with the
Administration’s commitment to
improving service delivery. By
qualitative feedback we mean
information that provides useful
insights on perceptions and opinions,
but are not statistical surveys that yield
quantitative results that can be
generalized to the population of study.

mstockstill on DSK4VPTVN1PROD with NOTICES

SUMMARY:

VerDate Mar<15>2010

17:17 May 16, 2014

Jkt 232001

This feedback will provide insights into
customer or stakeholder perceptions,
experiences and expectations, provide
an early warning of issues with service,
or focus attention on areas where
communication, training or changes in
operations might improve delivery of
products or services. These collections
will allow for ongoing, collaborative and
actionable communications between the
Agency and its customers and
stakeholders. It will also allow feedback
to contribute directly to the
improvement of program management.
Feedback collected under this generic
clearance will provide useful
information, but it will not yield data
that can be generalized to the overall
population. This type of generic
clearance for qualitative information
will not be used for quantitative
information collections that are
designed to yield reliably actionable
results, such as monitoring trends over
time or documenting program
performance. Such data uses require
more rigorous designs that address: The
target population to which
generalizations will be made, the
sampling frame, the sample design
(including stratification and clustering),
the precision requirements or power
calculations that justify the proposed
sample size, the expected response rate,
methods for assessing potential nonresponse bias, the protocols for data
collection, and any testing procedures
that were or will be undertaken prior
fielding the study. Depending on the
degree of influence the results are likely
to have, such collections may still be
eligible for submission for other generic
mechanisms that are designed to yield
quantitative results.
NPPD received no comments in
response to the 60-day notice published
in the Federal Register of December 19,
2013 (78 FR 244).
Below we provide National Protection
and Programs Directorate projected
average estimates for the next three
years:
Current Actions: New collection of
information.
Type of Review: New Collection.
Affected Public: Individuals and
households, businesses and
organizations, State, Local or Tribal
Government.
Estimated Number of Respondents:
Below is a preliminary estimate of the
aggregate burden hours for this generic
clearance. This estimate is based on a
review of past behavior of the
participating sub-components and by
several individual sub-components’
estimates for this ICR. In recognition
that individual sub-components will
differ in how often they use this generic

PO 00000

Frm 00075

Fmt 4703

Sfmt 4703

28745

clearance, this burden estimate assumes
that 2 sub-components would be the
heaviest users and account for
approximately ten times as great a
burden as the other sub-components
combined. NPPD sub-components will
provide more refined individual
estimates of burden in their subsequent
notices.
Average Expected Annual Number of
activities: 15.
Respondents: 14080.
Annual responses: 14080.
Frequency of Response: Once per
request.
Average minutes per response: 34
minutes.
Burden hours: 7920.3.
An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid
Office of Management and Budget
control number.
Dated: May 9, 2014.
Scott Libby,
Acting Chief Information Officer, National
Protection and Programs Directorate,
Department of Homeland Security.
[FR Doc. 2014–11389 Filed 5–16–14; 8:45 am]
BILLING CODE 9110–9P–P

DEPARTMENT OF HOMELAND
SECURITY
[Docket No. DHS–2013–0043]

General Meeting Registration and
Evaluation
National Protection and
Programs Directorate, DHS.
ACTION: 30-day notice and request for
comments; new information collection
request: 1670—NEW.
AGENCY:

The Department of Homeland
Security (DHS), National Protection and
Programs Directorate (NPPD, Office of
Cybersecurity and Communications
(CS&C), Office of Emergency
Communications (OEC), will submit the
following information collection request
(ICR) to the Office of Management and
Budget (OMB) for review and clearance
in accordance with the Paperwork
Reduction Act of 1995 (Pub. L. 104–13,
44 U.S.C. Chapter 35). NPPD is
soliciting comments concerning New
Information Collection Request, General
Meeting Registration and Evaluation.
DHS previously published this ICR in
the Federal Register on March 17, 2011,
at 76 FR 52, for a 60-day public
comment period. DHS received no
comments. The purpose of this notice is
to allow an additional 30 days for public
comments.

SUMMARY:

E:\FR\FM\19MYN1.SGM

19MYN1


File Typeapplication/pdf
File Modified2014-05-17
File Created2014-05-17

© 2024 OMB.report | Privacy Policy